Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53. [electronic resource]
Producer: 20090217Description: 619-24 p. digitalISSN:- 1476-5594
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Azo Compounds -- pharmacology
- Cell Line, Transformed
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor -- methods
- Humans
- Neoplasms -- drug therapy
- Nitric Oxide -- metabolism
- Piperazines -- pharmacology
- Prodrugs -- pharmacology
- Tumor Suppressor Protein p53
- Ubiquitin -- metabolism
- Ubiquitin-Activating Enzymes -- antagonists & inhibitors
- Ubiquitination -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.